NCT07266415

Brief Summary

This study aims to evaluate the safety and efficacy of sleep inducing digital sound application on pregnant women in their 1st and 2nd trimester with insomnia

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
0mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress97%
Jun 2025May 2026

First Submitted

Initial submission to the registry

April 20, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

June 24, 2025

Completed
5 months until next milestone

First Posted

Study publicly available on registry

December 5, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 18, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 18, 2026

Expected
Last Updated

December 5, 2025

Status Verified

June 1, 2025

Enrollment Period

9 months

First QC Date

April 20, 2025

Last Update Submit

November 24, 2025

Conditions

Keywords

insomniapregnancy

Outcome Measures

Primary Outcomes (1)

  • Primary outcome measurement

    Insomnia severity index

    1 week

Secondary Outcomes (13)

  • Sleep Latency (SL, Minutes), assessed using a sleep diary

    1 week

  • Sleep Latency (SL, Minutes), assessed using a smartwatch

    1 week

  • Sleep Efficiency (SE, Percentage), assessed using a sleep diary

    1 week

  • Sleep Efficiency (SE, Percentage), assessed using a smartwatch

    1 week

  • Wake After Sleep Onset (WASO, Minutes), assessed using a sleep diary

    1 week

  • +8 more secondary outcomes

Study Arms (3)

Experimental group

EXPERIMENTAL
Device: Sleep inducing digital sound application

Sham-controlled group

SHAM COMPARATOR
Device: Provides meaningless sound in application

Control group

PLACEBO COMPARATOR

Sleep Hygiene Education in application

Device: Provides Sleep hygiene education text in application

Interventions

Application: BELL-001

Experimental group

Sham application intervention

Sham-controlled group

Placebo application

Control group

Eligibility Criteria

Age19 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years older
  • pregnant women in their 1st and 2nd trimester
  • suffering from insomnia symptom
  • scored 10 or high in screening ISI
  • a person who voluntarily agreed to participate in this RCT

You may not qualify if:

  • Has a confirmed diagnosis of insomnia disorder other than chronic insomnia based on DSM-5(ex. Narcolepsy, Periodic Limb Movement, Restless Leg syndrome, etc)
  • Has a confirmed diagnosis of other neuropsychiatric disease
  • Has an history of suicidal ideat or attempt
  • Shift worker
  • Going through other interventions regarding insomnia(sleeping pills, light therapy, other alternative interventions)
  • Has a severe auditory, visual, or cognitive impairment
  • A person who cannot familiarize with the usage of smartphones and digital applications
  • Has a history of alcohol or other substance use disorder
  • A person with high risk pregnancy considered inadequate to participate in this trial by obstetric experts
  • A person considered inadequate to participate in this trial by a clinical expert

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 13620, South Korea

Location

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 20, 2025

First Posted

December 5, 2025

Study Start

June 24, 2025

Primary Completion

March 18, 2026

Study Completion (Estimated)

May 18, 2026

Last Updated

December 5, 2025

Record last verified: 2025-06

Locations